About Bioline  All Journals  Testimonials  Membership  News  Donations

Tropical Journal of Pharmaceutical Research
Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria
ISSN: 1596-5996
EISSN: 1596-9827
Vol. 13, No. 3, 2014, pp. 319-325
Bioline Code: pr14046
Full paper language: English
Document type: Research Article
Document available free of charge

Tropical Journal of Pharmaceutical Research, Vol. 13, No. 3, 2014, pp. 319-325

 en Evaluation of In vitro and In vivo Performance of Granisetron In situ Forming Implants: Effect of Sterilization, Storage Condition and Degradation
Algın-Yapar, Evren; Arı, Nuray & Baykara, Tamer


Purpose: To investigate the effect of various solvent systems and gamma irradiation on the in vitro and in vivo performance of granisetron HCl injectable phase-sensitive in situ forming implants (ISFIs).
Methods: ISFIs were prepared by mixing and sterilized by gamma irradiation. Effect of solvent system was studied. Injectability, polymer degradation and stability studies (4 and 25 °C for 4 months), viscosity measurements, as well as in vitro and in vivo (in rabbits) drug release, and also histological examinations for biocompatibility studies (in rabbits and rats) were carried out.
Results: ISFIs showed good injectability from 20-gauge needle and their in vitro drug release increased in the following rank order of solvent/solvent combinations: dimethylsulphoxide (DMSO) > DMSO:prophylenecarbonate (PC) > DMSO:triacetin(TA) > DMSO:benzylbenzoate (BB). DMSO:PC incorporating ISFI gave zero order (r2= 0.9503) drug release for 21 days; application of gamma irradiation accelerated drug release with a difference factor (f1) of 53 but zero order release (r2 = 9690) was maintained. Following test results for DMSO:PC including ISFI as decrease in molecular weight of polymer was descriptive for drug release behavior and sterilization effect, additionally dynamic viscosities decreased in line with polymer degradation and all forms of this ISFI showed plastic flow (fresh, irradiated, aged at 4 and 25 °C for 4 months). In vivo performance showed steady state plasma drug concentrations between 2 to 21 days with value of 0.55 ± 0.03 μg/ml and biocompatibility was confirmed by histological results obtained at specific stages of tissue reactions, and also by lack of fibrous capsule formation.
Conclusion: An ISFI for long-term antiemetic therapy achieved in this preliminary study is promising and, therefore, further investigations are required.

Implant; Poly(DL-lactide-co-glycolide); Granisetron; Gamma irradiation; Sterilization; Degradation; Viscosity; Stability; Pharmacokinetic; Biocompatibility

© Copyright 2014 - Tropical Journal of Pharmaceutical Research
Alternative site location:

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2022, Site last up-dated on 10-Dec-2021.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Internet Data Center of Rede Nacional de Ensino e Pesquisa, RNP, Brazil